Loading...
OTCM
GMVDF
Market cap0kUSD
Jul 06, Last price  
0.00USD
1Q
0.00%
IPO
-100.00%
Name

G Medical Innovations Holdings Ltd

Chart & Performance

D1W1MN
OTCM:GMVDF chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
269.07%
Revenues
4m
-10.91%
00083,9562,367,7803,886,5334,900,0004,961,0004,420,000
Net income
-25m
L+66.89%
-1,992,0000-3,016,000-20,840,495-13,127,184-10,907,754-12,536,000-14,758,000-24,629,000
CFO
-18m
L+60.77%
-1,794,0000-2,503,0000-11,951,800-6,297,000-4,647,000-11,494,000-18,479,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

G Medical Innovations Holdings Ltd, along with its affiliated companies, operates as an early-stage commercial healthcare enterprise. It specializes in creating advanced mobile health and remote medical solutions for markets in the United States, China, and Israel. The company's product portfolio features Prizma, a user-friendly medical device that records vital signs, integrates with electronic medical records, and generates reports adhering to clinical standards. Another key offering is the Extended Holter Patch System, a multi-channel wearable biosensor designed for continuous electrocardiogram data collection for up to two weeks. Furthermore, it is developing a Wireless Vital Signs Monitoring System, intended for real-time and ongoing tracking of physiological parameters and biometrics. Beyond its devices, G Medical Innovations provides monitoring services, encompassing both independent diagnostic testing facility oversight and private patient monitoring. The company was established in 2014 and maintains its headquarters in Rehovot, Israel.
IPO date
Oct 26, 2017
Employees
84
Domiciled in
KY
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT